CJC 1295 (NO DAC) IPAM

CJC-1295 No DAC + Ipamorelin is one of the most widely researched peptide combinations in growth hormone optimization and recovery-focused protocols. This advanced dual-peptide blend combines CJC-1295 No DAC, a modified Growth Hormone-Releasing Hormone (GHRH) analog, with Ipamorelin, a selective Growth Hormone Secretagogue (GHS), to support natural pulsatile growth hormone release through complementary mechanisms.

\r\n

Together, these peptides are commonly researched for their potential synergistic effects on recovery, body composition, sleep quality, lean muscle support, metabolic function, and healthy aging applications.

\r\n

CJC-1295 No DAC

\r\n

CJC-1295 No DAC, also known as Modified GRF 1-29, is a shorter-acting GHRH analog designed to stimulate the pituitary gland’s natural release of growth hormone in a more physiologic pulsatile manner. Unlike the DAC (Drug Affinity Complex) version, the No DAC variant has a shorter half-life and is commonly researched for producing more controlled GH pulses that mimic natural secretion patterns.

\r\n

Research involving CJC-1295 No DAC has explored:

\r\n

\r\n
• Growth hormone and IGF-1 pathway support
\r\n
• Recovery and regeneration research
\r\n
• Lean muscle preservation studies
\r\n
• Sleep and recovery optimization
\r\n
• Anti-aging and wellness protocols
\r\n

\r\n

Ipamorelin

\r\n

Ipamorelin is a selective ghrelin receptor agonist and Growth Hormone Secretagogue (GHS) researched for stimulating endogenous GH release with minimal effects on cortisol, prolactin, and appetite pathways compared to older GHRPs.

\r\n

Research involving Ipamorelin commonly focuses on:

\r\n

\r\n
• Recovery support and tissue regeneration
\r\n
• Sleep quality research
\r\n
• Lean muscle and body recomposition studies
\r\n
• Healthy aging applications
\r\n
• Metabolic optimization protocols
\r\n

\r\n

Why This Combination Is Popular

\r\n

CJC-1295 No DAC and Ipamorelin are frequently researched together because they stimulate growth hormone release through different yet complementary pathways:

\r\n

\r\n
• CJC-1295 No DAC supports GHRH receptor signaling
\r\n
• Ipamorelin activates ghrelin/GHS receptors
\r\n

\r\n

This dual-action mechanism is believed to support stronger and more physiologic GH pulsatility compared to either peptide alone.

\r\n

Researchers commonly investigate this combination for:

\r\n

\r\n
• Recovery and regeneration support
\r\n
• Lean muscle maintenance research
\r\n
• Fat metabolism and body recomposition
\r\n
• Exercise recovery protocols
\r\n
• Sleep quality and nighttime recovery
\r\n
• Healthy aging and wellness applications
\r\n
• GH and IGF-1 optimization studies
\r\n

\r\n

Because the No DAC version is shorter acting, this stack is often preferred in research protocols seeking more natural GH pulse timing and flexibility.

\r\n

Key Features

\r\n

\r\n
• Advanced dual GH-support peptide blend
\r\n
• Combines GHRH and GHS pathways
\r\n
• Research-backed recovery and body composition stack
\r\n
• Supports natural pulsatile GH release research
\r\n
• Studied for sleep, recovery, and lean muscle support
\r\n
• Popular in anti-aging and wellness protocols
\r\n
• Minimal cortisol and prolactin activity compared to older GHRPs
\r\n

\r\n

Research Use Notice

\r\n

This product is intended strictly for laboratory and research purposes only. It is not approved for human consumption or medical use.